Efficacy of brentuximab vedotin in allogeneic stem cell transplanted patients with relapsed/refractory hodgkin lymphoma
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 21 Sep 2016 New trial record